Abstract
This study examined whether a heart or kidney graft could provide protection for the more resistant skin graft. Buffalo rat recipients were given a single dose of RIB 5/2 (non-depleting anti-CD4 mAb) plus i.v. Lewis splenocytes 21 days before being given Lewis heart or kidney grafts. Lewis skin was grafted either simultaneously with, or after, long-term (>50 days) Lewis heart or kidney allograft acceptance. Immune responsiveness was analyzed by in vitro mixed lymphocyte culture (MLC), cytotoxic T lymphocytes (CTLs), and limiting dilution analysis (LDA). While i.v. alloantigen plus RIB 5/2 resulted in long-term acceptance of heart and kidney, survival of skin grafts alone was not prolonged. However, simultaneous transplantation with kidney, but not heart, resulted in long-term skin graft acceptance, while skin grafts subsequently grafted to recipients tolerant to kidney or heart were not accepted. In vitro analysis revealed a down-regulation of proliferation, cytotoxicity, and precursor T-helper cells (pThs)/precursor cytotoxic T lymphocytes (pCTLs) in Buffalo recipients accepting Lewis kidney and skin allografts. While RIB 5/2 plus Lewis splenocytes do not prolong the survival of skin grafts, Lewis skin grafted simultaneously with a kidney, but not heart, is accepted indefinitely and provides donor-specific protection for a subsequent skin graft.
Similar content being viewed by others
References
Arima T, Lehmann M, Flye MW (1997) Induction of donor-specific transplantation tolerance to cardiac allografts following treatment with non-depleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Transplantation 63:284–288
Billingham R, Medawar P (1952) The technique of free skin grafting in mammals. Br J Exp Biol 28:385–402
Calhoun R, Mohanakumar T, Flye MW (1996) Tissue- and organ-specific immune responses: role in human disease and allograft immunity. Transplant Rev 10:34–39
Davis HS, Kamada N, Roser BJ (1983) Mechanisms of donor-specific unresponsiveness induced by liver grafting. Transplant Proc 15:831–832
Fabre J, Lim SH, Morris PJ (1971) Renal transplantation in the rat: details of a technique. Aust N Z J Surg 41:69–75
Flye MW, Pennington L, Kirkman R, Weber B, Sindelar W, Sachs DH (1999) Spontaneous acceptance or rejection of orthotopic liver transplants in outbred and partially inbred miniature swine. Transplantation 68:599–607
Herbert J, Roser B (1988) Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation 46 [2 Suppl]:128S–134S
Horneff G, Emmrich F, Reiter C, Kalden JR, Burmester GR (1992) Persistent depletion of CD4+ T cells and inversion of the CD4/CD8 T cell ratio induced by anti-CD4 therapy. J Rheumatol 19:1845–1850
Johnson LL, Bailey DW, Mobraaten LE (1981) Genetics of histocompatibility in mice. IV. Detection of certain minor (non-H-2) H antigens in selected organs by the popliteal lymph node test. Immunogenetics 14:63–71
Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS (1983) Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1:143–173
Lautenschlager I, Nyman N, Vaananen H, Lehto VP, Virtanen L, Häyry P (1983) Antigenic and immunogenic components in rat liver. Scand J Immunol 17:61–68
Lehmann M, Sternkopf F, Metz F, Brock J, Docke WD, Plantikow A, Kuttler B, Hahn HJ, Ringel B, Volk HD (1992) Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 54:959–962
Madsen JC, Peugh WN, Wood KJ, Morris PJ (1987) The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 44:849–852
Manca F, Barocci S, Kunkl A, Gurreri G, Costantini M, Celada F (1983) Recognition of donor fibroblast antigens by lymphocytes homing in the human grafted kidney. Transplantation 36:670–674
Moreland LW, Pratt PW, Bucy RP, Jackson BS, Feldman JW, Koopman WJ (1994) Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term follow-up of CD4+ T cell counts. Arthritis Rheum 37:834–838
Motoyama K, Arima T, Lehmann M, Flye MW (1997) Tolerance to heart and kidney grafts induced by non-depleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Surgery 122:213–219
Motoyama K, Lehmann M, Flye MW (1999) Analysis of donor-specific unresponsiveness to rat allografts by non-depleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen. Transplant Proc 31:1237–1238
Motoyama K, Arima T, Yu S, Lehmann M, Flye MW (2000) The kinetics of tolerance induction by non-depleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Transplantation 69:285–293
Naji A, Barker CF, Silvers WK (1979) Relative vulnerability of isolated pancreatic islets, parathyroid, and skin allografts to cellular and humoral immunity. Transplant Proc 11:560–562
Nakafusa Y, Goss JA, Mohanakumar T, Flye MW (1993) Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen. Transplantation 55:877–882
Ono K, Lindsey ES (1969) Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57:225–229
Poindexter NJ, Naziruddin B, McCourt DW, Mohanakumar T (1995) Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. J Immunol 154:3880–3887
Poindexter NJ, Steward NS, Shenoy S, Jendrisak MD, Flye MW, Howard TK, Mohanakumar T (1995) Cytolytic T lymphocytes from human renal allograft biopsies are tissue-specific. Hum Immunol 44:43–49
Reinherz EL, Schlossman, SF (1980) The differentiation and function of human T lymphocytes. Cell 19:821–827
Savas CP, Nolan MS, Lindsey NJ, Boyle PF, Slater DN, Fox M (1985) Renal transplantation in the rat—a new simple, non-suture technique. Urol Res 13:91–93
Shizuru JA, Gregory AK, Chao CT, Fathman CG (1987) Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 237:278–280
Shizuru JA, Seydel KB, Flavin TF, Wu AP, Kong CC, Hoyt EG, Fujimoto N, Billingham ME, Starnes VA, Fathman CG (1990) Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 50:366–373
Shizuru JA, Alters SE, Fathman CG (1992) Anti-CD4 monoclonal antibodies in therapy: creation of non-classical tolerance in adults. Immunol Rev 129:105–130
Siegling A, Lehmann M, Riedel H, Platzer C, Brock J, Emmrich F, Volk HD (1994) A non-depleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 57:464–467
Steinmuller D (1998) The enigma of skin allograft rejection. Transplant Rev 12:42–57
Steinmuller D, Wachtel SS (1980) Transplantation biology and immunogenetics of murine skin-specific (Sk) alloantigens (review). Transplant Proc 12:100–106
Steinmuller D, Wakely E, Landas SK (1991) Evidence that epidermal alloantigen Epa-I is an immunogen for murine heart as well as skin allograft rejection. Transplantation 51:459–463
Sun J, Sheil AG, Wang C, Wang L, Rokahr K, Sharland A, Jung SE, Li L, McCaughan GW, Bishop GA (1996) Tolerance to rat liver allografts. IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation 62:1725–1730
Swain SL (1983) T cell subsets and the recognition of MHC class. Immunol Rev 74:129–142
Tak PP, van der Lubbe PA, Cauli A, Daha MR, Smeets TJ, Kluin PM, Meinders AE, Yanni G, Panayi GS, Breedveld FC (1995) Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 38:1457–1465
Takeuchi E, Ishikura H, Ishizu A, Harada H, Kato H, Yasuda K, Yoshiki T (1997) Induced expression of Thy-1 molecules on dermal endothelial cells in skin allografts. Pathol Res Pract 193:623–627
Teh HS, Garvin AM, Forbush KA (1991) Participation of CD4 coreceptor molecules in T cell repertoire selection. Nature 349:241–243
van der Lubbe PA, Reiter C, Breedveld FC, Kruger K, Schattenkirchner M, Sanders ME, Riethmuller G (1993) Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis. Arthritis Rheum 36:1375–1379
Wustrack KO, Gruber RP, Lucas ZJ (1975) Immunologic enhancement of skin allografts in the rat: role of vascular and lymphatic reconstitution. Transplantation 19:156–165
Zuniga-Pflucker JC, McCarthy SA, Weston M, Longo DL, Singer A, Kruisbeek AM (1989) Role of CD4 in thymocyte selection and maturation. J Exp Med 169:2085–2096
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Margenthaler, J.A., Yu, S., Otomo, N. et al. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft. Transpl Int 16, 713–720 (2003). https://doi.org/10.1007/s00147-003-0599-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00147-003-0599-x